S

Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506

Watchlist Manager
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Watchlist
Price: 307 CNY -4.95% Market Closed
Market Cap: 123.1B CNY

Relative Value

The Relative Value of one Sichuan Biokin Pharmaceutical Co Ltd stock under the Base Case scenario is 11.94 CNY. Compared to the current market price of 307 CNY, Sichuan Biokin Pharmaceutical Co Ltd is Overvalued by 96%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
11.94 CNY
Overvaluation 96%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
10
Median 3Y
40.9
Median 5Y
40.9
Industry
2.6
Forward
54.9
vs History
vs Industry
21
Median 3Y
-58.4
Median 5Y
-58.4
Industry
21.5
Forward
1 823.7
vs History
vs Industry
22
Median 3Y
-63.4
Median 5Y
-63.4
Industry
16.6
vs History
0
vs Industry
24
Median 3Y
9.3
Median 5Y
9.3
Industry
24
vs History
41
vs Industry
3
Median 3Y
31.1
Median 5Y
31.1
Industry
2.1
vs History
0
vs Industry
10
Median 3Y
40.8
Median 5Y
40.8
Industry
2.7
Forward
53.2
vs History
0
vs Industry
15
Median 3Y
61.7
Median 5Y
61.7
Industry
5.3
vs History
vs Industry
19
Median 3Y
-57.9
Median 5Y
-57.9
Industry
12.8
Forward
-1 492.9
vs History
vs Industry
22
Median 3Y
-57.9
Median 5Y
-57.9
Industry
16.2
Forward
-2 134.3
vs History
vs Industry
24
Median 3Y
-61.3
Median 5Y
-61.3
Industry
14.9
vs History
vs Industry
24
Median 3Y
-58
Median 5Y
-58
Industry
17.7
vs History
3
vs Industry
1
Median 3Y
61.5
Median 5Y
61.5
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Sichuan Biokin Pharmaceutical Co Ltd Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
123.1B CNY 287.6 -67.3 -62.3 -62.3
US
Eli Lilly and Co
NYSE:LLY
749.9B USD 15.3 67.5 36.2 39.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
366.6B USD 4.1 16.8 12.3 16.1
DK
Novo Nordisk A/S
CSE:NOVO B
2.1T DKK 7 20.4 14.1 16.2
CH
Roche Holding AG
SIX:ROG
206B CHF 3.4 24.9 9.4 10.9
CH
Novartis AG
SIX:NOVN
186.1B CHF 4.3 17.7 10.4 14
UK
AstraZeneca PLC
LSE:AZN
163.4B GBP 4 28.2 130.8 197.2
US
Merck & Co Inc
NYSE:MRK
197B USD 3.1 11.3 8.4 10.2
IE
Endo International PLC
LSE:0Y5F
163.5B USD 70.5 -56 261.3 655.3
US
Pfizer Inc
NYSE:PFE
136.4B USD 2.2 17.3 7.4 10.5
P/E Multiple
Earnings Growth PEG
CN
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Average P/E: 25.5
Negative Multiple: -67.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
67.5
50%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
16.8
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
20.4
18%
1.1
CH
Roche Holding AG
SIX:ROG
24.9
32%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
UK
AstraZeneca PLC
LSE:AZN
28.2
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.3
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.3
31%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Average EV/EBITDA: 433.7
Negative Multiple: -62.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.2
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.3
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
14.1
13%
1.1
CH
Roche Holding AG
SIX:ROG
9.4
5%
1.9
CH
Novartis AG
SIX:NOVN
10.4
5%
2.1
UK
AstraZeneca PLC
LSE:AZN
130.8
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.4
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
2%
3.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Average EV/EBIT: 1 867.2
Negative Multiple: -62.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.6
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.1
13%
1.2
DK
Novo Nordisk A/S
CSE:NOVO B
16.2
14%
1.2
CH
Roche Holding AG
SIX:ROG
10.9
6%
1.8
CH
Novartis AG
SIX:NOVN
14
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
197.2
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.2
11%
0.9
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.5
10%
1